Advanced Enzyme [ADVENZYMES] vs Tanfac Industries [TANFACIND] Detailed Stock Comparison

Advanced Enzyme Technologies Ltd.

NSE
Loading...

Tanfac Industries Ltd.

BSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Advanced Enzyme Technologies Ltd. wins in 13 metrics, Tanfac Industries Ltd. wins in 7 metrics, with 0 ties. Advanced Enzyme Technologies Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Advanced Enzyme Technologies Ltd. Tanfac Industries Ltd. Better
P/E Ratio (TTM) 22.00 66.26 Advanced Enzyme Technologies Ltd.
Price-to-Book Ratio 2.26 14.61 Advanced Enzyme Technologies Ltd.
Debt-to-Equity Ratio 2.26 9.28 Advanced Enzyme Technologies Ltd.
PEG Ratio 1.68 -0.85 Advanced Enzyme Technologies Ltd.
EV/EBITDA 14.17 41.73 Advanced Enzyme Technologies Ltd.
Profit Margin (TTM) 21.46% 10.85% Advanced Enzyme Technologies Ltd.
Operating Margin (TTM) 22.76% 12.17% Advanced Enzyme Technologies Ltd.
EBITDA Margin (TTM) 22.76% 12.17% Advanced Enzyme Technologies Ltd.
Return on Equity 8.93% 28.25% Tanfac Industries Ltd.
Return on Assets (TTM) 8.09% 20.67% Tanfac Industries Ltd.
Free Cash Flow (TTM) $1.08B $-641.87M Advanced Enzyme Technologies Ltd.
Dividend Yield 1.56% 0.34% Advanced Enzyme Technologies Ltd.
1-Year Return 19.31% 29.08% Tanfac Industries Ltd.
Price-to-Sales Ratio (TTM) 4.72 7.19 Advanced Enzyme Technologies Ltd.
Enterprise Value $28.07B $49.64B Tanfac Industries Ltd.
EV/Revenue Ratio 3.96 7.20 Advanced Enzyme Technologies Ltd.
Gross Profit Margin (TTM) 75.92% 36.49% Advanced Enzyme Technologies Ltd.
Revenue per Share (TTM) $63 $346 Tanfac Industries Ltd.
Earnings per Share (Diluted) $13.60 $37.53 Tanfac Industries Ltd.
Beta (Stock Volatility) 0.45 -0.21 Tanfac Industries Ltd.

Advanced Enzyme Technologies Ltd. vs Tanfac Industries Ltd. Stock Performance Analysis

Loading Price Chart...

ADVENZYMES
TANFACIND

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Advanced Enzyme Technologies Ltd.-3.02%4.06%10.87%32.74%26.61%28.96%
Tanfac Industries Ltd.-2.08%3.72%-15.95%0.07%2.17%-4.61%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Advanced Enzyme Technologies Ltd.19.31%28.94%-12.28%27.81%27.81%27.81%
Tanfac Industries Ltd.29.08%107.16%1,664.40%11,884.41%13,950.69%11,143.65%

Performance & Financial Health Analysis: Advanced Enzyme Technologies Ltd. vs Tanfac Industries Ltd.

MetricADVENZYMESTANFACIND
Market Information
Market Cap i₹33.43B₹49.61B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i171,02222,308
90 Day Avg. Volume i152,50816,696
Last Close₹380.25₹2,012.00
52 Week Range₹251.95 - ₹419.00₹1,450.55 - ₹2,585.00
% from 52W High-9.25%-22.17%
All-Time High₹571.00 (Sep 16, 2024)₹5,064.30 (Aug 29, 2025)
% from All-Time High-33.41%-60.27%
Growth Metrics
Quarterly Revenue Growth0.02%-0.03%
Quarterly Earnings Growth0.13%-0.55%
Financial Health
Profit Margin (TTM) i0.21%0.11%
Operating Margin (TTM) i0.23%0.12%
Return on Equity (TTM) i0.09%0.28%
Debt to Equity (MRQ) i2.269.28
Cash & Liquidity
Book Value per Share (MRQ)₹132.60₹170.18
Cash per Share (MRQ)₹54.16₹14.38
Operating Cash Flow (TTM) i₹1.70B₹523.26M
Levered Free Cash Flow (TTM) i₹1.31B₹881.47M
Dividends
Last 12-Month Dividend Yield i1.56%0.34%
Last 12-Month Dividend i₹5.20₹16.00

Valuation & Enterprise Metrics Analysis: Advanced Enzyme Technologies Ltd. vs Tanfac Industries Ltd.

MetricADVENZYMES (Apr 24, 2026)TANFACIND (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i22.0066.26
Forward P/E i19.30N/A
PEG Ratio i1.68-0.85
Price to Sales (TTM) i4.727.19
Price to Book (MRQ) i2.2614.61
Market Capitalization
Market Capitalization i₹33.43B₹49.61B
Enterprise Value i₹28.07B₹49.64B
Enterprise Value Metrics
Enterprise to Revenue i3.967.20
Enterprise to EBITDA i14.1741.73
Risk & Other Metrics
Beta i0.45-0.21
Book Value per Share (MRQ) i₹132.60₹170.18

Financial Statements Comparison: Advanced Enzyme Technologies Ltd. vs Tanfac Industries Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricADVENZYMES (2025)TANFACIND (2025)
Revenue/Sales i6.37B5.51B
Cost of Goods Sold i1.65B3.18B
COGS % of Revenue i25.9%57.8%
Gross Profit i4.72B2.32B
Gross Margin i74.1%42.2%
Research & Development i8.75MN/A
Operating Income (EBIT) i1.61B1.21B
Operating Margin i25.2%22.0%
EBITDA i2.23B1.29B
EBITDA Margin i35.0%23.4%
Pre-Tax Income i1.87B1.19B
Pre-Tax Income % of Revenue i29.4%21.6%
Income Tax i533.90M306.14M
Income Tax % of Revenue i8.4%5.6%
Net Income (Profit) i1.34B881.47M
Profit Margin i21.0%16.0%

Balance Sheet & Liquidity Metrics

MetricADVENZYMES (2025)TANFACIND (2025)
Cash & Equivalents i942.25M301.18M
Total Current Assets i8.80B2.46B
Total Current Assets % of Revenue i138.2%44.8%
Total Current Liabilities i967.55M1.08B
Total Current Liabilities % of Revenue i15.2%19.6%
Long-Term Debt i209.17MN/A
Long-Term Debt % of Revenue i3.3%0.0%
Total Shareholders Equity i14.69B3.12B
Retained Earnings i11.53B2.62B
Retained Earnings % of Revenue i181.2%47.6%
Property, Plant & Equipment i2.93B1.68B

Cash Flow Statement Comparison

MetricADVENZYMES (2025)TANFACIND (2025)
Operating Cash Flow i1.70B523.26M
Operating Cash Flow % of Revenue i26.7%9.5%
Capital Expenditures i-332.81M-968.83M
Free Cash Flow i1.08B-641.87M
FCF Margin i16.9%-11.7%
Debt Repayment i-58.08MN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricADVENZYMESTANFACIND
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i111.93M19.95M
Float Shares i36.89M7.01M
% Held by Insiders i55.52%70.86%
% Held by Institutions i18.75%0.03%
% Held by Public i25.73%29.11%

Dividend Analysis & Yield Comparison: Advanced Enzyme Technologies Ltd. vs Tanfac Industries Ltd.

MetricADVENZYMESTANFACIND
Last 12-Month Dividend i₹5.20₹16.00
Last 12-Month Dividend Yield i1.56%0.34%
3-Year Avg Annual Dividend i₹5.43₹7.50
3-Year Avg Dividend Yield i0.75%0.30%
3-Year Total Dividends i₹16.30₹22.50
Ex-Dividend DateJul 23, 2025Sep 17, 2025